Hoya sees stability in Q2 lens business as US sales fall, value-added products grow
Hoya Corporation saw stability in the second quarter of fiscal year 2026 in sales of its Health Care business, which comprises the group’s eyeglass-lens and contact-lens activities, with revenues for the division edging up by 0.7 percent compared to the year earlier to 120.0 billion Japanese yen (€682.1m).
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.